Profile | GDS4284 / 224865_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 2178.94 | 85 |
GSM687648 | Patient 402 control | 3420.09 | 90 |
GSM687653 | Patient 403 control | 3712.89 | 91 |
GSM687658 | Patient 404 control | 4561.53 | 93 |
GSM687663 | Patient 411 control | 4541.64 | 93 |
GSM687668 | Patient 422 control | 3706.89 | 91 |
GSM687673 | Patient 424 control | 4679.51 | 93 |
GSM687678 | Patient 425 control | 3506.12 | 90 |
GSM687683 | Patient 427 control | 3329.43 | 90 |
GSM687688 | Patient 428 control | 4715.47 | 93 |
GSM687695 | Patient 441 control | 4102.3 | 92 |
GSM687699 | Patient 443 control | 2686 | 88 |
GSM687704 | Patient 444 control | 3514.17 | 90 |
GSM687707 | Patient 448 control | 3566.98 | 91 |
GSM687712 | Patient 449 control | 3034.27 | 89 |
GSM687719 | Patient 450 control | 3956.76 | 92 |
GSM687724 | Patient 451 control | 4511.34 | 93 |
GSM687728 | Patient 452 control | 8234.16 | 96 |
GSM687646 | Patient 401 treated 24h | 3556.79 | 90 |
GSM687649 | Patient 402 treated 24h | 4084.37 | 92 |
GSM687665 | Patient 411 treated 24h | 4438.34 | 93 |
GSM687651 | Patient 402 treated 4 weeks | 4199.99 | 92 |
GSM687667 | Patient 411 treated 4 weeks | 4115.63 | 92 |
GSM687670 | Patient 422 treated 24h | 4262.6 | 92 |
GSM687671 | Patient 422 treated 4 weeks | 3444.88 | 90 |
GSM687654 | Patient 403 treated 24h | 3476.42 | 90 |
GSM687675 | Patient 424 treated 24h | 3821.15 | 91 |
GSM687685 | Patient 427 treated 24h | 4262.55 | 92 |
GSM687656 | Patient 403 treated 4 weeks | 3119.58 | 89 |
GSM687677 | Patient 424 treated 4 weeks | 4455.38 | 92 |
GSM687687 | Patient 427 treated 4 weeks | 3212.13 | 89 |
GSM687692 | Patient 428 treated 4h | 4055.7 | 92 |
GSM687716 | Patient 449 treated 4h | 3377.6 | 90 |
GSM687722 | Patient 450 treated 4h | 4341.33 | 92 |
GSM687680 | Patient 425 treated 24h | 4274.71 | 92 |
GSM687690 | Patient 428 treated 24h | 4390.36 | 92 |
GSM687700 | Patient 443 treated 24h | 4419.47 | 93 |
GSM687705 | Patient 444 treated 24h | 3993.09 | 91 |
GSM687714 | Patient 449 treated 24h | 3037.06 | 89 |
GSM687721 | Patient 450 treated 24h | 4394.55 | 93 |
GSM687682 | Patient 425 treated 4 weeks | 4093.31 | 92 |
GSM687694 | Patient 428 treated 4 weeks | 3657.23 | 90 |
GSM687702 | Patient 443 treated 4 weeks | 3423.78 | 90 |
GSM687718 | Patient 449 treated 4 weeks | 2380.14 | 86 |
GSM687723 | Patient 450 treated 4 weeks | 3823.24 | 91 |
GSM687661 | Patient 404 treated 4h | 3189.78 | 89 |
GSM687710 | Patient 448 treated 4h | 2950.07 | 89 |
GSM687726 | Patient 451 treated 4h | 4753.74 | 93 |
GSM687730 | Patient 452 treated 4h | 1305.16 | 79 |
GSM687660 | Patient 404 treated 24h | 5263.64 | 94 |
GSM687697 | Patient 441 treated 24h | 6621.51 | 95 |
GSM687709 | Patient 448 treated 24h | 2915.6 | 88 |
GSM687725 | Patient 451 treated 24h | 4386.65 | 92 |
GSM687729 | Patient 452 treated 24h | 10111 | 97 |
GSM687727 | Patient 451 treated 4 weeks | 4740.88 | 93 |
GSM687731 | Patient 452 treated 4 weeks | 5883.57 | 95 |